Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and...

Descripción completa

Detalles Bibliográficos
Autor principal: White, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777025/
https://www.ncbi.nlm.nih.gov/pubmed/31581941
http://dx.doi.org/10.1186/s12936-019-2955-z
_version_ 1783456549697486848
author White, Nicholas J.
author_facet White, Nicholas J.
author_sort White, Nicholas J.
collection PubMed
description Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination.
format Online
Article
Text
id pubmed-6777025
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67770252019-10-11 Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance White, Nicholas J. Malar J Debate Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination. BioMed Central 2019-10-11 /pmc/articles/PMC6777025/ /pubmed/31581941 http://dx.doi.org/10.1186/s12936-019-2955-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
White, Nicholas J.
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title_full Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title_fullStr Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title_full_unstemmed Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title_short Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
title_sort triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777025/
https://www.ncbi.nlm.nih.gov/pubmed/31581941
http://dx.doi.org/10.1186/s12936-019-2955-z
work_keys_str_mv AT whitenicholasj tripleartemisinincontainingcombinationantimalarialtreatmentsshouldbeimplementednowtodelaytheemergenceofresistance

Ejemplares similares